There are several differnces between Cloud9 and Emesyl. Emesyl targets a much larger audience, it is legal internationally, and developed by a person that has recognizably been extremely succesful with a similar product.
Although my investment in Itonis is miniscule (under $7500), compared to others in my portfolio, I fully expect Emesyl to come to fruitation and be a tremendous success. I also look forward to other products coming forth from the efforts of Dr Hensley.
Be it as it may right now, I think I have made a sound investment and look forward to growth in Itonis.
News 
Market Data 
Discover 
AI
